BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25823816)

  • 1. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
    Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
    Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.
    Ecke I; Petry F; Rosenberger A; Tauber S; Mönkemeyer S; Hess I; Dullin C; Kimmina S; Pirngruber J; Johnsen SA; Uhmann A; Nitzki F; Wojnowski L; Schulz-Schaeffer W; Witt O; Hahn H
    Cancer Res; 2009 Feb; 69(3):887-95. PubMed ID: 19155313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
    Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
    Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
    Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
    Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog-independent overexpression of transforming growth factor-beta1 in rhabdomyosarcoma of Patched1 mutant mice.
    Eichenmüller M; Bauer R; Von Schweinitz D; Hahn H; Kappler R
    Int J Oncol; 2007 Aug; 31(2):405-12. PubMed ID: 17611698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.
    Tostar U; Malm CJ; Meis-Kindblom JM; Kindblom LG; Toftgård R; Undén AB
    J Pathol; 2006 Jan; 208(1):17-25. PubMed ID: 16294371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
    Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
    Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: novel targets for gastric cancer.
    Song Y; Tian Y; Zuo Y; Tu JC; Feng YF; Qu CJ
    Mol Med Rep; 2013 Apr; 7(4):1159-68. PubMed ID: 23440386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing.
    Uhmann A; Ferch U; Bauer R; Tauber S; Arziman Z; Chen C; Hemmerlein B; Wojnowski L; Hahn H
    Int J Oncol; 2005 Dec; 27(6):1567-75. PubMed ID: 16273213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbalanced overexpression of the mutant allele in murine Patched mutants.
    Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
    Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons.
    Nagao K; Toyoda M; Takeuchi-Inoue K; Fujii K; Yamada M; Miyashita T
    Genomics; 2005 Apr; 85(4):462-71. PubMed ID: 15780749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
    Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
    Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.
    Zibat A; Uhmann A; Nitzki F; Wijgerde M; Frommhold A; Heller T; Armstrong V; Wojnowski L; Quintanilla-Martinez L; Reifenberger J; Schulz-Schaeffer W; Hahn H
    Carcinogenesis; 2009 Jun; 30(6):918-26. PubMed ID: 19321799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
    Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
    BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the PTCH coding region in human rhabdomyosarcoma.
    Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H
    Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice.
    Zurawel RH; Allen C; Wechsler-Reya R; Scott MP; Raffel C
    Genes Chromosomes Cancer; 2000 May; 28(1):77-81. PubMed ID: 10738305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays.
    Löf-Öhlin ZM; Levanat S; Sabol M; Sorbe B; Nilsson TK
    Int J Oncol; 2011 Mar; 38(3):685-92. PubMed ID: 21206974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
    Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
    Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice.
    Wakabayashi Y; Mao JH; Brown K; Girardi M; Balmain A
    Nature; 2007 Feb; 445(7129):761-5. PubMed ID: 17230190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.